advertisement
Li T 11
Showing records 1 to 11 | Display all abstracts from Li T86859 Frequency of Abstracts Presented at Eye and Vision Conferences Being Developed Into Full-Length Publications: A Systematic Review and Meta-analysis
E JY
JAMA ophthalmology 2020; 0: 689-697
86119 Acupuncture for glaucoma
Law SK
Cochrane Database of Systematic Reviews 2020; 2: CD006030
86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Li T; Wang Y
Drug Delivery 2020; 27: 410-421
86119 Acupuncture for glaucoma
Wang L
Cochrane Database of Systematic Reviews 2020; 2: CD006030
86859 Frequency of Abstracts Presented at Eye and Vision Conferences Being Developed Into Full-Length Publications: A Systematic Review and Meta-analysis
Ramulu PY
JAMA ophthalmology 2020; 0: 689-697
86119 Acupuncture for glaucoma
Li T
Cochrane Database of Systematic Reviews 2020; 2: CD006030
86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Chen J
Drug Delivery 2020; 27: 410-421
86859 Frequency of Abstracts Presented at Eye and Vision Conferences Being Developed Into Full-Length Publications: A Systematic Review and Meta-analysis
Fapohunda K; Li T
JAMA ophthalmology 2020; 0: 689-697
86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Gao X; Pan S
Drug Delivery 2020; 27: 410-421
86859 Frequency of Abstracts Presented at Eye and Vision Conferences Being Developed Into Full-Length Publications: A Systematic Review and Meta-analysis
Scherer RW
JAMA ophthalmology 2020; 0: 689-697
86339 Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
Su Y; Zhou X
Drug Delivery 2020; 27: 410-421
